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ABSTRACT
Nitric oxide (NO) overproduction by inducible nitric oxide synthase (iNOS) may be associated with acute and chronic 
inflammations. Macrophages as important cells in the innate immune system are able to be stimulated and can lead to 
iNOS activation and excessive NO production. Gynura procumbens is a medicinal plant traditionally used in treating 
various ailments including inflammation but the mechanism of anti-inflammatory activity of this plant is still elusive. 
This study was carried out to investigate the anti-inflammatory therapeutic effects of Gynura procumbens ethanolic 
extract on NO production and iNOS protein expression in RAW 264.7 macrophages stimulated with lipopolysaccharide 
(LPS). Cell viability of RAW 264.7 macrophages treated with Gynura procumbens ethanolic extract was determined by 
MTT assay. NO production was determined by Griess assay following Gynura procumbens ethanolic extract treatment 
alone or in combination with LPS stimulation. Protein expression of iNOS was determined by western blot. RAW 264.7 
macrophages viability of more than 90% was observed after 24 h treatment with Gynura procumbens ethanolic extract 
concentration range of 3.9 µg/mL to 500 µg/mL. Significant inhibition of NO production level has been identified in 
LPS-stimulated RAW 264.7 cells pre-treated with 250 µg/mL Gynura procumbens ethanolic extract (p<0.05) while all 
selected concentrations of Gynura procumbens ethanolic extract showed no significant alteration of NO production in 
the absence of LPS stimulation. Pre-treatment of 250 µg/mL Gynura procumbens ethanolic extract also demonstrated 
significant suppression of iNOS protein expression in LPS-stimulated RAW 264.7 cells (p<0.05). In conclusion, this study 
demonstrates that Gynura procumbens ethanolic extract exhibits anti-inflammatory potential through inhibition of NO 
production and iNOS protein expression in LPS-stimulated macrophages, suggesting that this plant could be further 
researched for its beneficial use in inflammatory disorders.
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ABSTRAK
Penghasilan nitrik oksida (NO) yang berlebihan oleh sintase nitrik oksida teraruh (iNOS) mungkin boleh dikaitkan 
dengan radang akut dan kronik. Makrofaj sebagai sel yang penting dalam sistem keimunan inat berupaya dirangsang 
dan menyebabkan aktivasi iNOS dan penghasilan NO yang berlebihan. Gynura procumbens ialah tumbuhan perubatan 
tempatan yang digunakan secara tradisi untuk merawat pelbagai jenis penyakit termasuk radang namun mekanisme 
aktiviti anti-radang oleh tumbuhan ini masih sukar difahami. Kajian ini dijalankan untuk mengkaji kesan terapeutik 
anti-radang oleh ekstrak etanol Gynura procumbens terhadap penghasilan NO dan ekspresi protein iNOS dalam makrofaj 
RAW 264.7 yang dirangsang oleh lipopolisakarida (LPS). Kebolehhidupan sel makrofaj RAW 264.7 oleh rawatan ekstrak 
etanol Gynura procumbens ditentukan dengan asai MTT. Reagen Griess digunakan untuk menentukan penghasilan NO 
diikuti rawatan ekstrak etanol Gynura procumbens atau dengan gabungan rangsangan LPS. Ekspresi protein iNOS 
dikaji dengan pemblotan western. Di bawah rawatan ekstrak etanol Gynura procumbens selama 24 jam menggunakan 
kepekatan 3.9 µg/mL hingga 500 µg/mL, makrofaj RAW 264.7 menunjukkan kebolehhidupan sel lebih daripada 90%. 
Perencatan paras penghasilan NO yang signifikan telah dikenal pasti dalam sel RAW 264.7 yang dirangsang oleh LPS 
bersama pra-rawatan 250 µg/mL ekstrak etanol Gynura procumbens (p<0.05) manakala semua kepekatan ekstrak 
etanol Gynura procumbens yang dipilih menunjukkan tiada perubahan yang signifikan dalam penghasilan NO tanpa 
perangsangan LPS. Pra-rawatan 250 µg/mL ekstrak etanol Gynura procumbens juga mendemonstrasikan perencatan 
ekspresi protein iNOS yang signifikan dalam sel RAW 264.7 yang dirangsang oleh LPS (p<0.05). Kesimpulannya, kajian 
ini menunjukkan bahawa ekstrak etanol Gynura procumbens mempamerkan potensi anti-radang melalui perencatan 
penghasilan NO dan ekspresi protein iNOS dalam makrofaj yang dirangsang oleh LPS, menunjukkan bahawa tumbuhan 
ini boleh dikaji secara lebih lanjut tentang kegunaannya yang bermanfaat dalam gangguan keradangan.
Kata kunci: Gynura procumbens; lipopolisakarida; makrofaj; nitrik oksida; radang; sintase nitrik oksida teraruh
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INTRODUCTION
Nitric oxide (NO) is a vital intracellular and intercellular 
signaling molecule involved in a wide range of physiological 
regulation and pathophysiological mechanisms. This 
simple diatomic molecule is produced from L-arginine 
by three nitric oxide synthase (NOS) enzymes: endothelial 
NOS (eNOS), neuronal NOS (nNOS), and inducible NOS 
(iNOS) (Aktan 2004; Soufli et al. 2016). The constitutively 
expressed eNOS and nNOS are responsible in the 
production of low physiological levels of NO (Hämäläinen 
et al. 2007). The NO plays a role as biological mediator 
or host defense effector in neuronal system, vascular 
system and immune system. Yet, in contrast, the NO also 
acts as oxygen free radical and cytotoxic agent (Aktan 
2004). Tissue damage is one of the consequences of NO 
overproduction where this pathological condition may be 
associated with acute and chronic inflammations (Joo et 
al. 2014). iNOS, which is absent in normal resting cells, is 
responsible for prolonged production of excessive NO by 
the induction of immunostimulatory cytokines, bacterial 
products or infection in different types of cells including 
macrophages (Korhonen et al. 2005). 
 Macrophages are pivotal cells in the innate immune 
system that possess the ability in the resolution of 
inflammatory responses (Tabas & Bornfeldt 2016). This 
class of cells that are differentiated from circulating 
monocytes is the important immune player to engulf 
pathogens or damaged cells via phagocytosis and released 
of pro-inflammatory factors (Bobryshev et al. 2016). Other 
than the ability to promote inflammation, macrophages 
are also able to terminate the inflammatory response 
by deactivating or removing the mediators. Hence, 
the therapeutic intervention targeting the modulation 
of inflammatory mediators produced by macrophages 
is proposed as one of the possible route in controlling 
inflammatory associated diseases (Fujiwara & Kobayashi 
2005). 
 Cells of the myeloid lineage, which include 
macrophage, have been shown to be the primary cellular 
sensors for lipopolysaccharide (LPS) in mammalian 
immune system (Alexander & Rietschel 2001). Activation 
of macrophages can be achieved by the binding of 
bacterial LPS to toll-like receptor 4 (TLR4), which in turn 
induces both MyD88-dependent and MyD88-independent 
pathways in the cells. Subsequently, mitogen-activated 
protein kinases (MAPKs) and nuclear factor kappa-B (NF-
kB) signaling pathways are activated. The iNOS expression 
can be induced through the activation of multiple signal 
transduction pathways, including MAPKs (such as p38, 
ERK1/2 or JNK), NF-κB, PI3 kinase, and Janus tyrosine kinase 
(JAK)-signal transducers and activators of transcription 
(STATs). Accordingly, the binding of LPS is also able to 
stimulate macrophages to release cytokines and NO along 
with the activation of iNOS protein expression through 
multiple possible signaling pathways (Kim et al. 2007).
 In recent years, researches on phytochemicals 
are getting more attention as more phytoconstituents 
are reported to demonstrate pharmacological benefits 
including modulation of inflammatory responses. Gynura 
procumbens (Lour.) Merr. (Family Compositae), also 
commonly called longevity spinach or ‘Sambung Nyawa’ 
in Malay language, is a decumbent perennial herb which 
is traditionally used for treatment of various ailments 
including inflammation, rashes, fever and hypertension 
(Kamaruzaman & Noor 2017). The extract of Gynura 
procumbens exhibited inhibitory effect on the release 
of pro-inflammatory cytokine mediators such as IL-6, 
IL-8, MMP-1, MMP-9, TNF-α and IFN-γ (Kim et al. 2011; 
Wong et al. 2015) whilst the anti-inflammatory cytokine 
IL-10 was significantly boosted upon administration 
of Gynura procumbens extract in vivo (Wong et al. 
2015). Nonetheless, Gynura procumbens extract also 
showed potential in the medical usage as a topical anti-
inflammatory agent (Iskander et al. 2002). 
 Although the potential of Gynura procumbens extract 
in anti-inflammatory effect has been shown in vitro and 
in vivo, a more comprehensive investigation on anti-
inflammatory mechanism by Gynura procumbens extract 
is needed for the future development of therapeutic drug 
candidates treating illness related to inflammation. This 
study is the first to explore further the anti-inflammatory 
mechanism in Gynura procumbens ethanolic extract by 
focusing on the NO production and iNOS protein expression 
in activated macrophages as one of the current research 
aims to treat chronic inflammatory diseases is worked 
out by identifying substances that prevent excessive NO 
production (Taira et al. 2009).
MATERIALS AND METHODS
MATERIALS
Dimethyl sulfoxide (DMSO), Dulbecco’s modified 
eagle medium (DMEM), fetal bovine serum (FBS), 
penicillin/streptomycin, Nω-nitro-l-arginine methyl 
ester hydrochloride (L-NAME), lipopolysaccharide 
(LPS) from Salmonella enterica serotype typhimurium, 
[3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium 
bromide] (MTT) salts,  phosphate buffer saline 
(PBS), Griess reagent, bovine serum albumin (BSA), 
radioimmunoprecipitation assay (RIPA) lysis buffer and 
protease inhibitor cocktail (PIC) were obtained from 
Sigma-Aldrich, USA. Sodium nitrite (NaNO2) was obtained 
from Nacalai Tesque, Japan. Electrochemiluminescence 
(ECL) reagent was obtained from Thermo Scientific, 
USA. Bradford Protein Assay (BPA), Tris powder, 
glycine, sodium deococyl sulphate (SDS), Laemmli 
buffer, β-mercaptoethanol, Tris-HCL buffer pH8.8, 
Tris-HCL buffer pH6.8, ammonium persulphate (APS), 
acrylamide/bis solution 29:1 and N,N,N’-tetramethyl-
ethylenedeamine (TEMED) were purchased from Bio-Rad, 
USA. Monoclonal antibodies (iNOS, beta actin, HRP-linked 
secondary antibody) were obtained from Cell Signaling 
Technology, USA. PVDF membrane was obtained from 
Roche, Switzerland.
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PLANT EXTRACTION
The whole plant of Gynura procumbens was bought 
from Brightmark Sdn. Bhd, Semenyih, Malaysia and 
identified by botanist, School of Environmental and 
Natural Resource Sciences, Faculty of Science and 
Technology, Universiti Kebangsaan Malaysia. A specimen 
voucher of the plant was deposited in the herbarium of 
Universiti Kebangsaan Malaysia with a reference number 
UKMB40375. Extraction of Gynura procumbens was done 
by maceration with 80% ethanol by referring to Dianita 
et al. (2015). Dried plant weighing 250 g was soaked in 
80% ethanol in 2 L conical flask for three days at room 
temperature and was occasionally stirred. After three 
days, filtration was done and the maceration was repeated 
for another two times. The solvent in the filtrates was 
evaporated using rotary evaporator to concentrate the 
extract. The ethanolic crude extract was kept in amber 
bottles and the solvent was allowed to dry at room 
temperature followed by complete drying by freeze dryer. 
The extract was dissolved in DMSO and kept at 4°C until 
further use. The final concentration of DMSO in the culture 
medium was controlled at 0.1% (v/v).
CELL CULTURE
Murine macrophage cell line RAW 264.7 was obtained 
from ATCC and maintained in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% FBS, penicillin 
(100 units/mL) and streptomycin (100 μg/mL) at 37°C 
in 5% CO2 atmosphere. Replacement of media was done 
every two to three days. 
MTT ASSAY
To determine the RAW 264.7 cells viability under the 
treatment of Gynura procumbens extract, the cells 
were incubated with the extract at a wide range of 
concentration. The cell viability was evaluated by MTT 
assay which relied on the ability of metabolically active 
mitochondria in viable cells to cleave the MTT to form 
purple formazan. The RAW 264.7 cells were seeded in a 
96-well plate at 5 × 104 cells/well. The plate was incubated 
for 24 h in 37°C, 5% CO2 atmosphere. Then, the media 
was removed and replaced with Gynura procumbens 
extract (3.9 - 500 μg/mL) in serum free media. The 
vehicle control group are cells grown in serum free 
media containing 0.1% DMSO. After 24 h of treatment, 
tetrazolium salts (5 mg/mL, 20 μL) was added into each 
well. The metabolically active cells will reduce the dye 
to form purple formazan. After 4 h, the media containing 
MTT reagent was carefully discarded and 200 μL of DMSO 
was added to dissolve the intracellular formazan product. 
After gentle shaking at room temperature for 20 min, the 
absorbance was measured at 570 nm. The percentage of 
cell viability was calculated as (Optical Density sample)/
(Optical Density of vehicle control) × 100%.
GRIESS ASSAY
In the present study, Gynura procumbens extract was 
evaluated for the effect on NO production in non-stimulated 
and LPS-stimulated RAW264.7 cells. Griess assay was 
conducted to measure the amount of nitrite accumulation 
(a stable product of nitric oxide) as an indicator of NO 
production. RAW 264.7 cells were seeded in 96-well plate 
at 5 × 104 cells/well. After 23 h incubation ((37°C, 5% 
CO2 atmosphere), the cells were pre-treated with Gynura 
procumbens extract at 3.9 μg/mL, 15.63 μg/mL, 62.5 μg/
mL and 250 μg/mL in serum free media. Control group 
only contained serum free media while 0.1% DMSO in 
serum free media served as the vehicle control. Positive 
control group was treated with 500 μM L-NAME (non-
selective NOS inhibitor). After 1 h of pre-treatment, the 
cells were induced with 1 μg/mL LPS and incubated for 
another 24 h. Briefly, cell culture medium (100 μL) from 
each well was transferred to new 96-well plate and mixed 
with 100 μL of Griess reagent (1% sulfanilamide and 
0.1% naphthylethylenediamine dihydrochloride in 2.5% 
phosphoric acid). Subsequently, the mixture was incubated 
at room temperature for 10 min and the absorbance at 540 
nm was measured in a microplate reader. Fresh culture 
medium was used as a blank in every experiment. The 
quantity of nitrite was determined from a sodium nitrite 
(NaNO2) standard curve.
WESTERN BLOT
RAW 264.7 cells were seeded in 12-well plate at 5 × 105 
cells/well. 24 h after cell seeding, the complete media 
was replaced by serum free media for cell starvation 
and incubated overnight to achieve cell quiescent and 
synchronization of the cell cycles. The cells were pre-
treated with Gynura procumbens extract (3.9 μg/mL, 15.63 
μg/mL, 62.5 μg/mL and 250 μg/mL) and after 1 h the cells 
were induced with 1 μg/mL LPS. Following 8 h incubation, 
RAW 264.7 cells were washed with cold PBS twice and were 
scraped off from the well of cell culture plate. Cells were 
centrifuged to collect the cell pellet then resuspended in 
cell lysis buffer containing protease inhibitor cocktail. By 
using Bradford assay the protein concentrations of each 
sample were determined and normalized to equivalent 
protein concentration. Loading samples were prepared by 
adding Laemmli buffer and denatured for 5 min at 95°C. 
After loading the samples in the well of acrylamide gel, 
proteins were separated by running SDS-PAGE. Separated 
proteins were transferred onto PVDF membrane, non-
specific sites were blocked by incubation in 5% BSA 
solution for 1 h. Immunodetection was performed 
overnight at 4°C using primary antibodies against iNOS 
(monoclonal, 1:1000) or β-actin (monoclonal, 1:5000) 
as loading reference, followed by HRP-linked secondary 
antibodies (anti-rabbit IgG: 1:1000) for 1 h. Signal 
detection was done by chemiluminescence using the gel 
documentation camera.
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STATISTICAL ANALYSIS
All data were expressed as mean ± SEM (standard error of 
mean). Statistical analysis was performed by using SPSS 
Version 22.0. The data were analyzed using analysis of 
variance (ANOVA) followed by Tukey’s test. A value of 
p<0.05 was considered as significant.
RESULTS AND DISCUSSION
EFFECT OF Gynura procumbens EXTRACT ON                             
RAW 264.7 CELL VIABILITY
Under the treatment of Gynura procumbens extract for 24 
h, no significant cytotoxicity was reported as compared to 
0.1% DMSO vehicle control group. Generally, cell viability 
of RAW 264.7 was more than 90% of vehicle control (105 
± 4.42 %, 102 ± 0.65 %, 100 ± 0.80 %, 100 ± 0.65 %, 97 ± 
0.73 %, 99 ± 1.38 %, 98 ± 1.30 % and 94 ± 2.95 %) in the 
presence of 3.9, 7.8, 15.63, 31.25, 62.5, 125, 250 and 500 
μg/mL of Gynura procumbens extract, respectively (Figure 
1).  Hence, all the tested Gynura procumbens extract 
concentrations were safe for the treatment on RAW 264.7 
macrophages. With this result, Gynura procumbens extract 
concentrations of 3.9 µg/mL, 15.63 µg/mL, 62.5 µg/mL 
and 250 µg/mL were selected for subsequent experiments.
EFFECT OF Gynura procumbens EXTRACT ON NO   
PRODUCTION LEVEL IN RAW 264.7 CELLS
As shown in Figure 2(A), the presence of 0.1% DMSO 
in vehicle control had no effect on the NO production 
level as compared to the control group with only serum-
free media. Under all selected treatment concentrations, 
Gynura procumbens extract show no significant effects 
on the nitric oxide production level in non-stimulated 
RAW 264.7 cells.  
 LPS endotoxin originated from the cell wall of gram-
negative bacteria is able to activate macrophages and 
stimulate the production of pro-inflammatory cytokines 
(Joo et al. 2014; Nicholas et al. 2007) as well as the 
generation of pro-inflammatory mediator of NO by iNOS 
(Shi et al. 2014) in inflammation and host defense. 
Referring to Figure 2(B), the NO production level in 
RAW 264.7 cells significantly increased (p<0.001) by the 
activation of LPS as nitrite accumulation was recorded 
at 6.55 ± 0.37 µM. The treatment group with 500 µM 
Nω-nitro-l-arginine methyl ester hydrochloride (L-NAME) 
as positive control elucidated significant inhibition 
(p<0.001) in NO production induced by LPS. Accordingly, 
L-NAME as one of the L-arginine analogues, had been 
identified as non-selective NOS inhibitor (Kopincová et 
al. 2012; Łuszczki et al. 2011). 
 Pre-treatment of Gynura procumbens extract for 1 
h prior to LPS activation had shown inhibitory effect on 
NO production in a dose-dependent manner. As shown in 
Figure 2(B), the nitrite concentration in the LPS activated 
groups treated with increasing concentrations of Gynura 
procumbens extract were 5.65 ± 1.52 µM, 5.04 ± 0.95 
µM, 3.78 ± 0.37 µM and 2.06 ± 0.34 µM. The inhibitory 
effect of NO production in LPS-stimulated RAW 264.7 was 
significant (p<0.05) in cells pre-treated with 250 µg/mL 
Gynura procumbens extract. This significant inhibitory 
effect was comparable to the positive control group of 
500 μM L-NAME, which reduce the LPS-stimulated nitrite 
accumulation to 2.02 ± 0.26 µM. 
 Gynura procumbens have been identified as a 
source of phytochemical compounds such as flavonoids, 
alkaloids, volatile oils, stigmasterol, chlorophylls and 
carotenoids. The flavonoids that have been reported 
in Gynura procumbens are quercetin, kaempferol-3-
O-rutinoside and astragalin (Akowuah et al. 2002; 
Kaewseejan et al. 2012; Mustafizur Rahman & Al Asad 
2013; Rosidah et al. 2008; Sunarwidhi et al. 2014). 
Certain flavonoids possess the ability to suppress NO 
production in LPS-activated RAW 264.7 cells in which the 
reduction of iNOS enzyme expression might contribute to 
this inhibitory effect. Specifically, astragalin is a potent 
inhibitor of NO production via the downregulation of 
iNOS expression (Kim & Kim 2011; Li et al. 2014; Ma 
FIGURE 1. No cytotoxic effect of Gynura procumbens extract on RAW 264.7 cells when compared to vehicle 
control containing 0.1% DMSO. Values are mean ± SEM for three independent experiments (n = 3)
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et al. 2015). Similar to Gynura procumbens, some other 
plant species under the genus Gynura also exert inhibitory 
effect on NO production level. Gynura bicolor extract and 
compound 8,8’-(ethene-1,2-diyl)-dinaphtalene-1,4,5-
trio isolated from Gynura segetum have been shown to 
downregulate NO level in LPS-stimulated RAW 264.7 cells 
(Wu et al. 2013; Yuandani et al. 2017). 
 Based on the research by Byeon et al. (2012) and 
Shao et al. (2008), the plant polysaccharides isolated from 
Tripterygium wilfordii and Korean Red Ginseng possess 
the capacity to activate NO production in non-stimulated 
RAW 264.7 cells which are associated with enhanced 
iNOS transcription. A paradoxical effect of plant-based 
polysaccharides on macrophages is reported in these two 
studies as suppression of LPS-stimulated NO production 
and iNOS mRNA expression were also recorded. Thus, 
the inhibitory effect of Gynura procumbens extract in NO 
overproduction stimulated by LPS could possibly caused 
by the presence of polysaccharides in this plant but no 
detailed study has been done yet. 
EFFECT OF Gynura procumbens EXTRACT ON INOS PROTEIN 
EXPRESSION IN RAW 264.7 CELLS
Subsequent to the significant inhibition of LPS-stimulated 
NO production in the previous assay, western blot was 
carried out by using the same extract treatment groups 
with LPS-stimulated RAW 264.7 macrophages. By referring 
to the studied pharmacological effects of the identified 
phytoconstituents in Gynura procumbens, the mechanism 
of actions in NO production inhibition by this plant 
extract had been focused on iNOS protein expression. 
As shown in Figure 3, the iNOS protein expression was 
significantly stimulated by LPS  (p<0.0001) compared 
to the unstimulated control group. At the transcription 
level, NO production by iNOS is regulated where the gene 
encoding iNOS is transcriptionally silent in physiological 
condition. However, LPS will drastically induce NO level 
in macrophages (Jacobs & Ignarro 2001) via the toll-
like receptor dependent signaling pathways activation 
(Anderson 2000). 
FIGURE 2. Effects of Gynura procumbens extract on nitric oxide (NO) production by (A) non-stimulated 
or (B) LPS-stimulated RAW 264.7 cells. Values are mean ± SEM of three independent experiments (n = 3). 
Significant difference compared to LPS-stimulated group * (p<0.05); ** (p<0.001); *** (p<0.0001) 
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 With Gynura procumbens extract at 3.9, 15.63 and 
62.5 μg/mL respectively, the iNOS protein expression 
showed no significant alteration. The arbitrary unit of iNOS 
protein expression in LPS-stimulated RAW 264.7 cells pre-
treated with these three extract concentrations were 0.95 
± 0.04, 1.05 ± 0.04 and 0.96 ± 0.08. Complementary to 
the findings in NO production level in present study, the 
iNOS protein expression induced by LPS in RAW 264.7 
cells was significantly downregulated (p<0.05) with 250 
μg/mL Gynura procumbens extract pre-treatment. The 
LPS-stimulated iNOS protein expression was suppressed 
by 250 μg/mL Gynura procumbens extract to 0.61 ± 0.04 
arbitrary unit. In current study, the finding of NO inhibition 
through iNOS protein expression suppression is supported 
by the pharmacological effects of Gynura procumbens 
phytoconstituents as reported in previous studies (Kim 
& Kim 2011; Li et al. 2014; Ma et al. 2015). Based on 
previous research, astragalin and chlorogenic acid which 
are identified active compounds in Gynura procumbens 
(Li et al. 2015; Rosidah et al. 2008) could be the potential 
contributors of the inhibitory effect in LPS-stimulated NO 
production and iNOS protein expression (Hwang et al. 
2014; Kim & Kim 2011). 
 When exposed to inflammatory stimuli, macrophages 
secrete cytokines such as tumor necrosis factor alpha 
(TNF-α), IL-1, IL-6, IL-8, and IL-12 which can regulate iNOS 
expression by activating iNOS gene promoter (Tripathi et 
al. 2007). Meanwhile, mitogen-activated protein kinase 
(MAPK) pathway activation can be initiated by LPS and 
TNF-α (Harikrishnan et al. 2018). Subsequently, the nuclear 
factor kappa-B (NF-κB) and activator protein-1 (AP1) which 
are the key pro-inflammatory transcription factors, will 
also be activated (Salim et al. 2016). Two NF-κB binding 
sites are located on iNOS gene promoter, where full 
induction of iNOS by LPS activation can only be achieved 
when both of the binding sites are bound (Aldridge et 
al. 2008). In macrophages, LPS-stimulated NF-κB induce 
iNOS expression and further enhance NO production (Li 
et al. 2002). Extract from Gynura bicolor, another plant 
from the genus Gynura which was mentioned previously, 
possesses NO inhibition by suppressing LPS-stimulated 
NF-κB activation and subsequently decrease the iNOS 
protein level in a dose-dependent manner (Wu et al. 2013). 
Simultaneously, the astragalin also exerts inhibitory effect 
on NO and iNOS via NF-κB and MAPK signaling pathway 
(Kim & Kim 2011; Li et al. 2014; Ma et al. 2015).
 In a study performed by Wong et al. (2015), Gynura 
procumbens has been demonstrated to possess inhibitory 
effect on TNF-α and IFN-γ level in vivo. LPS is a potent 
inducer of TNF-α and IFN-γ production in macrophages 
(Kraaij et al. 2014). The pro-inflammatory IFN-γ is able 
to activate the Janus kinase (JAK) and Signal Transducer 
and Activator of Transcription (STAT) pathway, collectively 
known as the JAK/STAT pathway. Two other key transcription 
factors involved in the regulation of iNOS gene production 
are synthesized by the activation of the JAK/STAT pathway: 
The phosphorylated STAT1 dimers and the activated 
interferon regulatory factor-1 (IRF1) (Salim et al. 2016). 
Other than the suppression of TNF-α and IFN-γ levels, 
the modulation on MAPK, NF-κB and JAK/STAT signaling 
pathways are another potential mechanism of actions by 
Gynura procumbens extract in NO and iNOS suppression. 
Hence, it is worth to give more attention on the possible 
signaling pathway modulation by Gynura procumbens 
FIGURE 3. Effect of Gynura procumbens extract on inducible nitric oxide synthase (iNOS) protein expression by LPS-
stimulated RAW 264.7 cells. Representative image of iNOS protein expression in western blot analysis was shown above 
quantitative analysis bar chart. Beta actin was used as loading control. Values are mean ± SEM of four independent 
experiments (n = 4). Significant difference compared to LPS-stimulated group * (p<0.05); *** (p<0.0001)
iNOS
(130 kDA)
(42 kDA)
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extract to get a more comprehensive understanding and 
deeper insight into the role of this medicinal plant in 
diseases involving inflammation and immunomodulation.
CONCLUSION
The results presented in this study demonstrate that Gynura 
procumbens ethanolic extract has a high potential to 
suppress NO production level and iNOS protein expression 
in LPS-stimulated RAW 264.7 macrophages. The findings of 
this study provide evidence that support the traditional use 
of Gynura procumbens in the treatment of inflammatory 
diseases. With present findings and literature reviews, 
further exploration on potential and benefits of Gynura 
procumbens extract at molecular levels along with the 
discovery of key chemical constituents or bioactive 
molecules responsible for the anti-inflammatory activities 
are essential.
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